In ZINC since | Heavy atoms | Benign functionality |
---|---|---|
July 23rd, 2004 | 12 | Yes |
Popular Name: Gabapentin Gabapentin
Find On: PubMed — Wikipedia — Google
CAS Numbers: 360-70-3 , 60142-95-2 , 60142-96-3 , [60142-95-2] , [60142-96-3]
(1-Aminomethyl-cyclohexyl)-acetic acid
1-(Aminomethyl)Cyclohexaneacetic Acid
1-(Aminomethyl)CyclohexaneaceticAcid
2-(1-(Aminomethyl)cyclohexyl)acetic acid
2-[1-(Aminomethyl)cyclohexyl]acetic acid
2-[1-(Aminomethyl)cyclohexyl]acetic acid(Gabapentin)
60142-96-3; D00332; Gabapentin (JAN/USAN/INN); Gralise (TN); Neurontin (TN)
60142-96-3; Gabapentin; Prestwick_151
Type pH range | xlogP | Des A‑Pol Apolar desolvation (kcal/mol) | Des Pol Polar desolvation (kcal/mol) | H Don H-bond donors | H Acc H-bond acceptors | Chg Net charge | tPSA (Ų) | MWT Molecular weight (g/mol) | RB Rotatable bonds | DL |
---|---|---|---|---|---|---|---|---|---|---|
Ref Reference (pH 7) | 0.62 | 3.61 | -46.82 | 3 | 3 | 0 | 68 | 171.24 | 3 | ↓ |
Note Type | Comments | Provided By |
---|---|---|
mechanism | . | ZereneX Building Blocks |
MP | 166 | TCI |
MP | 169 - 171 | Enamine Building Blocks |
MP | 169...171 | Enamine Building Blocks |
ALOGPS_SOLUBILITY | 4.34e+00 g/l | DrugBank-approved |
purity | 9.500000000000000e+001 | Enamine Building Blocks Enamine Building Blocks |
Purity | 97% | Fluorochem |
Purity | >98. | Matrix Scientific |
Indications | analgesic, anticonvulsant | KeyOrganics Bioactives |
biological_use | Anticonvulsant | IBScreen Bioactives |
biological_use | CNS depressant | IBScreen Bioactives IBScreen Bioactives |
Target | GABA Receptor | Selleck Chemicals |
mechanism | GABA-like amino acid which penetrates the blood-brain barrier | IBScreen Bioactives IBScreen Bioactives |
Warnings | IRRITANT | Matrix Scientific |
UniProt Database Links | LAT1_HUMAN | ChEBI |
mechanism | regulator | IBScreen Bioactives |
mechanism | Voltage-gated N-type calcium ion channels | IBScreen Bioactives |
Code | Description | Organism Class | Affinity (nM) | LE (kcal/mol/atom) | Type |
---|---|---|---|---|---|
CA2D1-4-E | Voltage-gated Calcium Channel Alpha2/delta Subunit 1 (cluster #4 Of 4), Eukaryotic | Eukaryotes | 80 | 0.83 | Binding ≤ 10μM |
CA2D2-1-E | Voltage-gated Calcium Channel Alpha2/delta Subunit 2 (cluster #1 Of 2), Eukaryotic | Eukaryotes | 70 | 0.83 | Binding ≤ 10μM |
CA2D3-1-E | Voltage-gated Calcium Channel Alpha2/delta Subunit 3 (cluster #1 Of 2), Eukaryotic | Eukaryotes | 140 | 0.80 | Binding ≤ 10μM |
CA2D4-1-E | Voltage-gated Calcium Channel Alpha2/delta-4 Subunit (cluster #1 Of 2), Eukaryotic | Eukaryotes | 140 | 0.80 | Binding ≤ 10μM |
O77773-1-E | Voltage-dependent Calcium Channel Alpha2delta Subunit (cluster #1 Of 1), Eukaryotic | Eukaryotes | 70 | 0.83 | Binding ≤ 10μM |
CA2D1-1-E | Voltage-gated Calcium Channel Alpha2/delta Subunit 1 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 8900 | 0.59 | Functional ≤ 10μM |
Uniprot | Swissprot | Description | Affinity (nM) | LE (kcal/mol/atom) | Type |
---|---|---|---|---|---|
O77773_PIG | O77773 | Voltage-dependent Calcium Channel Alpha2delta Subunit, Pig | 140 | 0.80 | Binding ≤ 1μM |
CA2D1_RAT | P54290 | Voltage-gated Calcium Channel Alpha2/delta Subunit 1, Rat | 140 | 0.80 | Binding ≤ 1μM |
CA2D1_HUMAN | P54289 | Voltage-gated Calcium Channel Alpha2/delta Subunit 1, Human | 140 | 0.80 | Binding ≤ 1μM |
CA2D1_MOUSE | O08532 | Voltage-gated Calcium Channel Alpha2/delta Subunit 1, Mouse | 120 | 0.81 | Binding ≤ 1μM |
CA2D2_HUMAN | Q9NY47 | Voltage-gated Calcium Channel Alpha2/delta Subunit 2, Human | 140 | 0.80 | Binding ≤ 1μM |
CA2D2_RAT | Q8CFG6 | Voltage-gated Calcium Channel Alpha2/delta Subunit 2, Rat | 140 | 0.80 | Binding ≤ 1μM |
CA2D3_HUMAN | Q8IZS8 | Voltage-gated Calcium Channel Alpha2/delta Subunit 3, Human | 140 | 0.80 | Binding ≤ 1μM |
CA2D3_RAT | Q8CFG5 | Voltage-gated Calcium Channel Alpha2/delta Subunit 3, Rat | 140 | 0.80 | Binding ≤ 1μM |
CA2D4_HUMAN | Q7Z3S7 | Voltage-gated Calcium Channel Alpha2/delta-4 Subunit, Human | 140 | 0.80 | Binding ≤ 1μM |
O77773_PIG | O77773 | Voltage-dependent Calcium Channel Alpha2delta Subunit, Pig | 140 | 0.80 | Binding ≤ 10μM |
CA2D1_RAT | P54290 | Voltage-gated Calcium Channel Alpha2/delta Subunit 1, Rat | 140 | 0.80 | Binding ≤ 10μM |
CA2D1_HUMAN | P54289 | Voltage-gated Calcium Channel Alpha2/delta Subunit 1, Human | 140 | 0.80 | Binding ≤ 10μM |
CA2D1_MOUSE | O08532 | Voltage-gated Calcium Channel Alpha2/delta Subunit 1, Mouse | 120 | 0.81 | Binding ≤ 10μM |
CA2D2_HUMAN | Q9NY47 | Voltage-gated Calcium Channel Alpha2/delta Subunit 2, Human | 140 | 0.80 | Binding ≤ 10μM |
CA2D2_RAT | Q8CFG6 | Voltage-gated Calcium Channel Alpha2/delta Subunit 2, Rat | 140 | 0.80 | Binding ≤ 10μM |
CA2D3_HUMAN | Q8IZS8 | Voltage-gated Calcium Channel Alpha2/delta Subunit 3, Human | 140 | 0.80 | Binding ≤ 10μM |
CA2D3_RAT | Q8CFG5 | Voltage-gated Calcium Channel Alpha2/delta Subunit 3, Rat | 140 | 0.80 | Binding ≤ 10μM |
CA2D4_HUMAN | Q7Z3S7 | Voltage-gated Calcium Channel Alpha2/delta-4 Subunit, Human | 140 | 0.80 | Binding ≤ 10μM |
CA2D1_RAT | P54290 | Voltage-gated Calcium Channel Alpha2/delta Subunit 1, Rat | 8900 | 0.59 | Functional ≤ 10μM |
Description | Species |
---|---|
Adrenaline,noradrenaline inhibits insulin secretion | |
Depolarization of the Presynaptic Terminal Triggers the Opening of Calcium Chann | |
Regulation of insulin secretion |